Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and the older Revision: v3.4.1.SummaryDifference0.5%

- Check31 days agoChange DetectedA government funding lapse notice was added at the top of the page, warning that information may not be up to date and that the NIH Clinical Center is open, and the site revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check38 days agoChange DetectedAdded Show glossary option and a new 'Last Update Submitted that Met QC Criteria' label. Updated capitalization of 'No FEAR Act Data' and the page revision to v3.4.0 (from v3.3.4).SummaryDifference0.3%

- Check53 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the prior Revision: v3.3.3.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded a Locations section listing Texas as a study location. Replaced the old standalone 'Texas Locations' item with the consolidated Locations section.SummaryDifference0.2%

- Check102 days agoChange DetectedMinor editorial wording changes were made to the Publications section to describe automatic PubMed content, and a page revision version notice was updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.